Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy.

MLA

Backes, James M., et al. “Modified-Policosanol Does Not Reduce Plasma Lipoproteins in Hyperlipidemic Patients When Used Alone or in Combination with Statin Therapy.” Lipids, vol. 46, no. 10, Oct. 2011, pp. 923–29. EBSCOhost, https://doi.org/10.1007/s11745-011-3591-8.

APA

Backes, J. M., Gibson, C. A., Ruisinger, J. F., & Moriarty, P. M. (2011). Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy. Lipids, 46(10), 923–929. https://doi.org/10.1007/s11745-011-3591-8

Chicago

Backes, James M, Cheryl A Gibson, Janelle F Ruisinger, and Patrick M Moriarty. 2011. “Modified-Policosanol Does Not Reduce Plasma Lipoproteins in Hyperlipidemic Patients When Used Alone or in Combination with Statin Therapy.” Lipids 46 (10): 923–29. doi:10.1007/s11745-011-3591-8.